Study of 2.5 million children finds no link between MMR vaccine and autism
Evaluating the health records of over 2.5 million children, researchers found no evidence that receiving the measles, mumps, and rubella vaccine before age two increases the risk of a childhood autism diagnosis.
A comprehensive study of over 2.5 million children has found no association between receiving the measles, mumps, and rubella (MMR) vaccine before the age of two and an increased risk of developing autism. Published in The Pediatric Infectious Disease Journal, the research aimed to address the complexities surrounding vaccine safety and autism diagnoses by utilizing an age-anchored landmark analysis.
This method helped reduce bias by comparing vaccinated and unvaccinated children within specific age windows, rather than relying on traditional observational studies. The study analyzed data from Cosmos, an extensive electronic health record database, encompassing 2,560,035 children who had at least one primary care visit between 12 and 24 months of age.
The prevalence of autism in this sample was found to be 2.55 percent, which is lower than the national estimate due to the narrower diagnostic category used. By focusing on the specific diagnostic code for childhood autism and excluding children diagnosed with autism at or before 11 months of age, the researchers ensured that the vaccine had been administered before the diagnosis.
The findings suggest that the timing of the MMR immunization does not influence the likelihood of a child being diagnosed with autism, providing further evidence to dispel the persistent myth linking the vaccine to the developmental condition.
Brief written by urgent.news from PsyPost's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
